Hahn EG - Search Results

1

Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.

Gentner B, Wein A, Croner RS, Zeittraeger I, Wirtz RM, Roedel F, Dimmler A, Dorlaque L, Hohenberger W, Hahn EG, Brueckl WM. Gentner B, et al. Among authors: hahn eg. Anticancer Res. 2009 Jan;29(1):67-74. Anticancer Res. 2009. PMID: 19331134 Free article.

2

Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.

Stickel F, Jüngert B, Brueckl V, Schirner I, Brueckl WM, Männlein G, Hegewald J, Mühldorfer S, Bittorf B, Hohenberger W, Hahn EG, Wein A. Stickel F, et al. Among authors: hahn eg. Anticancer Drugs. 2003 Oct;14(9):745-9. doi: 10.1097/00001813-200310000-00010. Anticancer Drugs. 2003. PMID: 14551509

3

Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma.

Brueckl WM, Ballhausen WG, Förtsch T, Günther K, Fiedler W, Gentner B, Croner R, Boxberger F, Kirchner T, Hahn EG, Hohenberger W, Wein A. Brueckl WM, et al. Among authors: hahn eg. Dis Colon Rectum. 2005 Jun;48(6):1275-81. doi: 10.1007/s10350-004-0949-5. Dis Colon Rectum. 2005. PMID: 15793634

4

Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI).

Brueckl WM, Grombach J, Wein A, Ruckert S, Porzner M, Dietmaier W, Rümmele P, Croner RS, Boxberger F, Kirchner T, Hohenberger W, Hahn EG, Jung A. Brueckl WM, et al. Among authors: hahn eg. Cancer Lett. 2005 Jun 1;223(1):137-42. doi: 10.1016/j.canlet.2004.09.037. Epub 2004 Nov 2. Cancer Lett. 2005. PMID: 15890246

5

Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practice.

Brueckl WM, Herbst L, Lechler A, Fuchs F, Schoeberl A, Zirlik S, Klein P, Brunner TB, Papadopoulos T, Hohenberger W, Hahn EG, Wiest GH. Brueckl WM, et al. Among authors: hahn eg. Anticancer Res. 2006 Nov-Dec;26(6C):4825-32. Anticancer Res. 2006. PMID: 17214347 Free article.

6

Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

Brueckl WM, Schoeberl A, Wirtz RM, Murray S, Hahn EG, Wiest GH. Brueckl WM, et al. Among authors: hahn eg. J Thorac Oncol. 2008 Mar;3(3):314-6. doi: 10.1097/JTO.0b013e3181654423. J Thorac Oncol. 2008. PMID: 18317076 Free article.

7

Comparability of microarray data between amplified and non amplified RNA in colorectal carcinoma.

Croner RS, Lausen B, Schellerer V, Zeittraeger I, Wein A, Schildberg C, Papadopoulos T, Dimmler A, Hahn EG, Hohenberger W, Brueckl WM. Croner RS, et al. Among authors: hahn eg. J Biomed Biotechnol. 2009;2009:837170. doi: 10.1155/2009/837170. Epub 2009 Oct 11. J Biomed Biotechnol. 2009. PMID: 19826639 Free PMC article.

8

Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.

Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T, Hohenberger W, Hahn EG, Wein A. Boxberger F, et al. Among authors: hahn eg. Med Sci Monit. 2010 Feb;16(2):CR49-55. Med Sci Monit. 2010. PMID: 20110914 Clinical Trial.

9

Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine.

Brueckl WM, Heinze E, Milsmann C, Wein A, Koebnick C, Jung A, Croner RS, Brabletz T, Günther K, Kirchner T, Hahn EG, Hohenberger W, Becker H, Reingruber B. Brueckl WM, et al. Among authors: hahn eg. Cancer Lett. 2004 Jan 20;203(2):181-90. doi: 10.1016/j.canlet.2003.08.013. Cancer Lett. 2004. PMID: 14732226

10

Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas.

Boxberger F, Jüngert B, Brueckl V, Brueckl WM, Hautmann M, Hohenberger W, Hahn EG, Wein A. Boxberger F, et al. Among authors: hahn eg. Anticancer Drugs. 2003 Jan;14(1):87-90. doi: 10.1097/00001813-200301000-00012. Anticancer Drugs. 2003. PMID: 12544263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters